An experimental system was developed to analyse quantitatively specific B cells for various antigens in human B cell populations by polyclonal transformation and immunoglobulin production induced by in vitro infection with Epstein-Barr virus (EBV). EBV-infected cells were cultured in microtest plates for three weeks and specific antibody activities for sheep red blood cell (SRBC) were detected in the culture supernatants by hemolysis and those for phosphorylcholine (PC) and for hepatitis B surface antigen (HBsAg) by passive hemagglutination. It was shown that frequencies of positive cultures with specific antibodies followed one hit-type of Poisson's distribution. Large numbers of cultures showed specific antibody activities for SRBC and for PC with tonsillar lymphocytes obtained from four donors. On the other hand, positive cultures with anti-HBsAg antibodies were practically undetectable with three donors. With the fourth donor, however, quite a large fraction of cultures showed specific antibody activities for HBsAg. Frequencies of positive cultures with anti-HBsAg antibodies were further analysed with peripheral blood lymphocytes obtained from five donors with serum anti-HBsAg. Comparable frequencies of cultures were shown to be positive with anti-SRBC antibodies with these donors. The frequencies of cultures with anti-HBsAg antibodies were, however, quite variable among these donors. It was considered that these results directly reflected the sizes of clones with these specificities in human lymphocytes populations obtained from donors with various immunological histories.
growing lymphoblastoid cell lines, which retain several markers of B cells such as surface immunoglobulins (Ig) and complement receptors and actively produce secretory Ig (Jondal and Klein 1973 ; Rosen et al. 1977 ; Kirchner et al. 1979 ). In the previous study we investigated Ig-production of EBV-induced monoclonal cell lines and showed that every transformed clone actively produced a single 7g, i.e., one class of heavy chains and one type of light chains ). The result has clearly indicated that human B cells at various stages of differentiation concerning the class of Ig produced can be transformed by EBV.
The in vitro transformation of human B cells by EBV offers two unique possibilities. One is the establishment of human B cell lines producing antibodies with predetermined specificities (Steinitz et al. 1977 ; Zurawski et al. 1978 ; Kozbor et al. 1979 ; Tsuchiya et al. 1980; . The other is to use EBV operationally as a polyclonal B cell activator in human lymphocytes in order to induce every transformable B cell to produce Ig and to analyse specific B cells for various antigens in human B cell populations in normal and various diseased states. In fact, we have shown in the previous study that, in the culture supernatants of EBV-induced polyclonal cell lines derived from tonsillar lymphocytes, specific antibody activities for diphtheria toxin, sheep red blood cell (SRBC), streptolysin 0, dinitrophenyl (DNP) and phosphorylcholine (PC) could be detected with various frequencies and titers (Tsuchiya et al. 1980) .
The purpose of the present study was to develop an experimental system to analyse quantitatively specific B cells for various antigens in human B cell populations by transformation with EBV. We used a microculture system to reduce the numbers of transformed cells per culture so that the numbers of transformed specific B cells per culture were limiting, i.e., around one. SRBC, PC and hepatitis B virus surface antigen (HBsAg) were used as the target antigens for the screening of transformed specific B cells.
MATERIALS AND METHODS
Chemicals. PC was purchased from Sigma Chemical Co., St. Louis, Mo., USA. The calcium ions were precipitated with phosphate before use. Methyliodide was purchased from E. Merck, Darmstadt, West Germany. p-Diazonium phenylphosphorylcholine (DPPC) was prepared according to the procedure of Chesebro and Metzgar (1972) and stored at -80°C until use. All other chemicals used were of analytical grade, commercially available.
Antigen-erythrocyte conjugate. PC-coupled human type 0 red blood cells (PC-OHRBC) were prepared as described by Claflin et al. (1974) with slight modifications. 10µM of DPPC in 0.2 ml of solution was mixed with 10 ml of a 5% suspension of OHRBC in borate saline buffer (0.035 M Na2B40, and 0.08 M NaCI), pH 9.0, and the mixture was incubated at 37°C for 5 min with gentle agitation. PC-OHRBC were washed three times in cold phosphate buffered saline (PBS), pH 7.2, and resuspended in PBS. HBsAg-coupled SRBC and purified HBsAg (Hebsgencell-kit) were purchased from Midori Jugi Co., Osaka.
Preparation of human lymphocytes. Tonsils obtained from routine tonsillectomies were cut finely with scissors in Eagle's minimum essential medium (MEM). Dispersed cells were centrifuged on a Ficoll-Isopaque gradient (Boyum 1968 ) and cells in the interface were collected. After being washed three times in MEM, cells were cultured at 37°C overnight to remove glass-adhering cells and to check contaminations. The culture medium was RPMI-1640 supplemented with 20% heat-inactivated fetal calf serum (FCS) (Flow Lab., Rockville, Md., USA), 10 mM HEPES (Sigma), pH 7.2, 100 u/ml of penicillin and 100 µg/ml of streptomycin (hereafter simply referred to as the culture medium). Floating cells were pelleted by centrifugation and resuspended at a cell concentration of 1 X 10'/ml in FCS containing 10% (v/v) dimethylsulfoxide (DMSO) and 3% (w/v) glucose. The cell suspension was stored in 1 ml aliquots at -80°C until use.
Lymphocytes were also separated from heparinized umbilical cord blood and adult peripheral blood by centrifugation on a Ficoll-Isopaque gradient. Cells were cultured at 37°C overnight to remove glass-adhering cells and floating lymphocytes were collected by centrifugation and used for viral infection.
Virus. The cell line B95-8 (Miller and Lipman 1973) was used as the source of EBV. B95-8 cells were seeded at a cell concentration of 3 x 105/ml in the culture medium. The culture supernatants were harvested after seven days' culture at 37°C, passed through a 0.45 em Millipore filter and stored in 5 ml aliquots at -80°C until use. The virus titer was determined by the transformation assay of umbilical cord blood lymphocytes as described by Miller and Lipman (1973) . The titer of the virus stock used in the present study was 1040 50% transformation doses (TD50)/ml.
Virus infection and cell culture. The stored tonsillar lymphocytes were thawed rapidly at 41°C and washed three times in MEM. Viable cells were counted in 0.1% trypan blue in PBS (viability usually about 80%) and suspended in the culture medium at a cell concentration of 1 X 10'/ml. To one volume of this cell suspension, two times the volume of EBV suspension was added. The mixture was incubated at 37°C for 1 hr with occasional gentle agitation and diluted with the culture medium to give a cell concentration of 1 X 106/ml. The cell suspension was distributed in 0.2 to 0.1 ml volume in Falcon No. 3040 microtest plates or in 0.02 ml volume in Faclon No. 3034 microtest plates (Flacon Plastics, Oxnard, Ca., USA) and cultured at 37°C in a well humidified atmosphere of 5% CO2. A half of the medium was changed every three to four days. After three weeks of culture, the culture supernatants were individually harvested and specific antibody activities in the culture supernatants were detected.
Assays for specific antibody activities in the culture supernatants. Anti-SRBC antibodies in the culture supernatants were detected by hemolysis. Anti-PC and anti-HBsAg antibodies were detected by passive hemagglutination (PHA). To 0.025 ml of the culture supernatants diluted 1:1 with dilution buffer (MEM for anti-SRBC antibodies, PBS containing 2% FCS for anti-PC antibodies, and PBS containing 3% solubilized SRBC stroma and 1% normal rabbit serum for anti-HBsAg antibodies) in microtitration plates (Cooke Lab., Alexander Va., USA), 0.025 ml of 0.5% SRBC in MEM containing 5% fresh guinea pig serum as complement, or 0.025 ml of 0.5% PC-OHRBC or HBsAg-SRBC in the dilution buffer was added. The plates were incubated at 37°C for 1 hr and those culture supernatants which showed partial to complete hemolysis or hemagglutination were scored as positive with specific antibody activities. Positive culture supernatants were further titrated in the same manner.
The specificity of anti-PC antibodies in the culture supernatants was shown by PITA inhibition with free hapten PC and fully described in the previous study . The specificity of anti-HBsAg antibodies in the culture supernatants was shown by PHA inhibition with purified HBsAg as instructed in the Hebsgencell-kit.
Plaque forming cell assay. After the culture supernatants were harvested, cells in each culture were washed one time in MEM and resuspended in 0.1 ml of MEM. Anti-SRBC antibody producing cells in the cultured cells were detected by plaque forming cell (PFC) assay (Cunningham and Szenberg 1968) . EBV-infected tonsillar lymphocytes were cultured at a constant cell concentration of 1 X 106/ml but in different culture volumes in microtest plates so that the actual numbers of EBV-infected cells per culture were given as shown in Table 1 (2x105/O.2 ml, 1.5x105/O.15 ml, 1x105/O.1 ml, and 2x104/O.02 ml). In two weeks of culture, every culture showed active proliferation of lymphoblastoid cells. At three weeks of culture, the culture supernatants were individually harvested and antibody activities for SRBC and PC in the culture supernatants were determined by hemolysis and PHA, respectively. If the numbers of specific B cells transformed in these cultures were limiting and the assay methods used could detect antibody activities derived from even a single clone of transformed specific B cells, frequencies of positive cultures with these specific antibody activities should vary proportionally to the numbers of EBV-infected cells cultured. As shown in Table  1 , this was actually the case, and the frequencies of positive cultures with anti-SRBC or anti-PC antibodies showed proportional changes in accordance with the numbers of EBV-infected cells per culture with two donors. The culture supernatants of uninfected cells (2 X 105/culture) cultured in the same manner did not contain detectable specific antibody activities.
The data shown in Table 1 were further analysed by plotting the logarithms of the fractions of those cultures which did not show specific antibody activities, i. e., negative fractions, against the numbers of EBV-infected cells cultured. As shown in Fig. 1 , there existed linear relationships extrapolating 1.0 between the logarithms of negative fractions and the numbers of EBV-infected cells cultured. This indicated that the detection frequencies of positive cultures with either of these two specific antibody activities followed one hit-type of Poisson's distribution. The results clearly showed that the numbers of specific B cells transformed in these microcultures were limiting, i.e., around one per culture, and the assay methods used could detect specific antibody activities derived from a single clone of a transformed specific B cell. Table 2 shows the results of the screenings of specific antibody activities for SRBC, PC and HBsAg in the culture supernatants of EBV-infected tonsillar lymphocytes (2 X 105/culture) obtained from four donors. The same PHA assay was used to detect anti-HBsAg antibodies as with anti-PC antibodies, and the detection sensitivities of these assays were presumably of the same level, so that no further test for the dete ~tion sensitivity of the assay for anti-HBsAg antibodies as conducted in Table 1 was p ~rformed. It was remarkable that large fractions of cultures (60 to 80%) were pcnitive with anti-SRBC or anti-PC antibodies with the first three donors (Y.S., T.K, and TM.). Moreover, the frequencies of positive cultures with anti-SRBC antibodies and those with anti-PC antibodies were quite comparable with these donors, though the former is a complex erythrocyte antigen presumably with multiple antigenic determinants and the latter is a Fig. 1 . Titration of EBV-transformed specific B cells. For detail see Table 1 . 7%) . In the fourth donor, however, the frequency of positive cultures with anti-SRBC or anti-PC antibodies was comparatively low (14% and 19%, respectively), but quite a large number of cultures was positive with anti-HBsAg antibodies (32%). These results presumably indicated the sizes of clones with each specificity in these donors, reflecting the individuals' immunological states at the cellular level.
The specificity of anti-HBsAg antibodies was confirmed by PHA inhibition with purified HBsAg provided in the Hebsgencell-kit. Antibody activities of twelve positive cultures with PHA titers ranging from 23 to 29 were completely inhibited by preincubation with free HBsAg at 37°C for 1 hr. 2 X 105 EBV-infected tonsillar lymphocytes were cultured in 0.2 ml volume in microtest plates for three weeks. Specific antibody activities in the culture supernatants were detected and titrated by hemolysis for anti-SRBC antibodies and by PHA for anti-PC and anti-HBsAg antibodies.
Data shown were obtained from I.M. for anti-SRBC and anti-PC antibodies and from H.K, for antiHBsAg antibodies (Table 2) . positive cultures were wide-ranged, extending from 21 to 26 with anti-SRBC antibodies and from 21 to 29 with anti-PC and anti-HBsAg antibodies (the latter indirectly showed that the assays for anti-PC and anti-HBsAg antibodies were of similar sensitivity). A common and interesting feature of these histograms was that the titers of the positive cultures were roughly divided into two groups at 22 with anti-SRBC and anti-PC antibodies and 23 with anti-HBsAg antibodies. The results might indicate that EBV-transformed B cells were roughly divided into two populations, one of which was fully transformed and rapidly growing and the other of which was slowly growing or abortively transformed. Abortive transformation has been well documented with several DNA tumor viruses (Stoker 1968; Smith et al. 1972 ) and the same phenomenon may be encountered in EBV-induced transformation of human B cells. Further studies are needed to elucidate these problems.
The reliability of the screening of specific antibody activities in the culture supernatants for detection of transformed specific B cells in the cultures was further confirmed by PFC assays of these cultures. No cultures without anti-SRBC antibodies in the culture supernatants contained anti-SRBC antibody producing cells detectable by PFC assay. There were, however, small numbers of cultures which showed anti-SRBC antibodies in the culture supernatants (of low titers) but contained no antibody producing cells as revealed by PFC assay. In these cultures, anti-SRBC antibody producing cells might be producing antibodies of IgG class which cannot be revealed by direct PFC assay, or, more likely, antibody producing cells might have ceased to produce antibodies at the time of assay (three weeks of culture) because of abortive transformation. Fig. 3 shows the correlation of the titers of antibodies in the culture supernatants and the numbers of antibody producing cells detected by PFC assay in the anti-SRBC positive cultures. It could be concluded that there existed a close correlation between the antibody titers in the culture supernatants and the numbers of antibody producing cells in these cultures.
The frequencies of positive cultures with anti-HBsAg antibodies were further analysed in the culture supernatants of EBV-infected peripheral blood lymphocytes (1 X 105/culture) obtained from healthy donors with comparatively high serum titers of anti-HBsAg (Table 3) . Comparable frequencies of positive cultures with anti-SRBC antibodies were obtained with these donors (around 10%) except for N.K. (3%). On the other hand, the frequencies of positive cultures with anti-HBsAg antibodies were quite variable with these donors, ranging from <1.0% to 15%. The serum titers of anti-HBsAg and the frequencies of anti-HBsAg positive cultures were only roughly correlated and it might be considered that EBV-induced transformation of B cells directly revealed the immunological states of anti-HBsAg specific B cells of these sero-positive donors at the cellular level.
As shown in Fig. 1 , detection frequencies of transformed specific B cells in the microcultures followed one hit-type of Poisson's distribution. It means that from the frequencies of positive cultures, one can calculate the average numbers of transformed specific B cells per culture using the formula of Poisson's distribution. If one can know the total numbers of actually transformed cells in these cultures (frequencies of transformation), one can further determine the absolute frequencies of specific B cells in EBY-transformed B cell populations with each donor. Such studies will be described in future communications.
In conclusion, the present system may open a new approach to quantitative and functional analyses of human B cells with various specificities at the cellular Table 2) were cultured in 0.2 ml volume in microtest plates for three weeks. Anti-SRBC antibodies in the culture supernatants were detected and titrated by hemolysis and anti-SRBC antibody producing cells in the cultured cells were detected by PFC assay. 
